
Sudhakar Katakam
Examiner (ID: 1906, Phone: (571)272-9929 , Office: P/1671 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1676, 1658, 1621, 1671 |
| Total Applications | 1838 |
| Issued Applications | 1259 |
| Pending Applications | 128 |
| Abandoned Applications | 477 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16375120
[patent_doc_number] => 20200323962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => LIPOPHILIC PEPTIDE PRODRUGS
[patent_app_type] => utility
[patent_app_number] => 16/646644
[patent_app_country] => US
[patent_app_date] => 2018-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25334
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16646644
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/646644 | LIPOPHILIC PEPTIDE PRODRUGS | Sep 16, 2018 | Abandoned |
Array
(
[id] => 17712323
[patent_doc_number] => 11376302
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-05
[patent_title] => Methods for treating depression and major depressive disorder
[patent_app_type] => utility
[patent_app_number] => 16/645581
[patent_app_country] => US
[patent_app_date] => 2018-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 41
[patent_no_of_words] => 11035
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16645581
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/645581 | Methods for treating depression and major depressive disorder | Sep 5, 2018 | Issued |
Array
(
[id] => 16275492
[patent_doc_number] => 10758499
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-01
[patent_title] => Dermatitis treatment
[patent_app_type] => utility
[patent_app_number] => 16/117148
[patent_app_country] => US
[patent_app_date] => 2018-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 4959
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16117148
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/117148 | Dermatitis treatment | Aug 29, 2018 | Issued |
Array
(
[id] => 18634926
[patent_doc_number] => 11759497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Daptomycin formulations
[patent_app_type] => utility
[patent_app_number] => 16/642462
[patent_app_country] => US
[patent_app_date] => 2018-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5889
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642462
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/642462 | Daptomycin formulations | Aug 27, 2018 | Issued |
Array
(
[id] => 13593315
[patent_doc_number] => 20180348206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => PROPHYLACTIC AND THERAPEUTIC AGENTS FOR FGFR3 DISEASES AND SCREENING METHOD FOR THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/059462
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16059462
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/059462 | PROPHYLACTIC AND THERAPEUTIC AGENTS FOR FGFR3 DISEASES AND SCREENING METHOD FOR THE SAME | Aug 8, 2018 | Abandoned |
Array
(
[id] => 13589819
[patent_doc_number] => 20180346458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => BENZAZOLE COMPOUNDS AND METHODS FOR MAKING AND USING THE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/057687
[patent_app_country] => US
[patent_app_date] => 2018-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16057687
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/057687 | Benzazole compounds and methods for making and using the compounds | Aug 6, 2018 | Issued |
Array
(
[id] => 14196645
[patent_doc_number] => 10265408
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-23
[patent_title] => Cleavable conjugates of antibiotics and an antibacterial cell-penetrating peptide
[patent_app_type] => utility
[patent_app_number] => 16/050472
[patent_app_country] => US
[patent_app_date] => 2018-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8811
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16050472
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/050472 | Cleavable conjugates of antibiotics and an antibacterial cell-penetrating peptide | Jul 30, 2018 | Issued |
Array
(
[id] => 17378131
[patent_doc_number] => 11236128
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-01
[patent_title] => Method of preparing stapled peptides
[patent_app_type] => utility
[patent_app_number] => 16/635472
[patent_app_country] => US
[patent_app_date] => 2018-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 7426
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16635472
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/635472 | Method of preparing stapled peptides | Jul 30, 2018 | Issued |
Array
(
[id] => 16111561
[patent_doc_number] => 20200207803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => CYCLATIVE RELEASE OF PEPTIDIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/633969
[patent_app_country] => US
[patent_app_date] => 2018-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14400
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16633969
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/633969 | Cyclative release of peptidic compounds | Jul 26, 2018 | Issued |
Array
(
[id] => 16153831
[patent_doc_number] => 20200215148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => METHOD FOR PRODUCING COMPLEX CONTAINING PROTEIN FOR MEDICAL USE AND POLYAMINO ACID, AND COMPLEX CONTAINING PROTEIN FOR MEDICAL USE AND POLYAMINO ACID
[patent_app_type] => utility
[patent_app_number] => 16/633350
[patent_app_country] => US
[patent_app_date] => 2018-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16633350
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/633350 | METHOD FOR PRODUCING COMPLEX CONTAINING PROTEIN FOR MEDICAL USE AND POLYAMINO ACID, AND COMPLEX CONTAINING PROTEIN FOR MEDICAL USE AND POLYAMINO ACID | Jul 23, 2018 | Abandoned |
Array
(
[id] => 15768799
[patent_doc_number] => 20200115417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => A CYCLIC PEPTIDE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR INHIBITING PROLIFERATION OF HEV
[patent_app_type] => utility
[patent_app_number] => 16/627516
[patent_app_country] => US
[patent_app_date] => 2018-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627516
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/627516 | A CYCLIC PEPTIDE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR INHIBITING PROLIFERATION OF HEV | Jul 22, 2018 | Abandoned |
Array
(
[id] => 16335639
[patent_doc_number] => 10786577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-29
[patent_title] => Pharmaceutical composition comprising glutatione disulfide and glutathione disulfide S-oxide
[patent_app_type] => utility
[patent_app_number] => 16/603042
[patent_app_country] => US
[patent_app_date] => 2018-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11531
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603042
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/603042 | Pharmaceutical composition comprising glutatione disulfide and glutathione disulfide S-oxide | Jul 16, 2018 | Issued |
Array
(
[id] => 13823785
[patent_doc_number] => 20190015377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => Compositions for Use in Treating Pulmonary Arterial Hypertension
[patent_app_type] => utility
[patent_app_number] => 16/036291
[patent_app_country] => US
[patent_app_date] => 2018-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16036291
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/036291 | Compositions for Use in Treating Pulmonary Arterial Hypertension | Jul 15, 2018 | Abandoned |
Array
(
[id] => 15993409
[patent_doc_number] => 20200172575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/628586
[patent_app_country] => US
[patent_app_date] => 2018-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16628586
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/628586 | Peptide compound and application thereof, and composition containing peptide compound | Jul 4, 2018 | Issued |
Array
(
[id] => 16831042
[patent_doc_number] => 11007273
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-18
[patent_title] => Prochelators as targeted prodrugs for prostate cancer and methods of making and using same
[patent_app_type] => utility
[patent_app_number] => 16/628358
[patent_app_country] => US
[patent_app_date] => 2018-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 31
[patent_no_of_words] => 15316
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16628358
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/628358 | Prochelators as targeted prodrugs for prostate cancer and methods of making and using same | Jul 2, 2018 | Issued |
Array
(
[id] => 13519547
[patent_doc_number] => 20180311316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5
[patent_app_type] => utility
[patent_app_number] => 16/025832
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 733
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16025832
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/025832 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5 | Jul 1, 2018 | Abandoned |
Array
(
[id] => 13504483
[patent_doc_number] => 20180303784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => OMEGA-3 COMPOSITIONS, DOSAGE FORMS, AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/023904
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7281
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16023904
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/023904 | Omega-3 compositions, dosage forms, and methods of use | Jun 28, 2018 | Issued |
Array
(
[id] => 15481253
[patent_doc_number] => 10555952
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-11
[patent_title] => Pharmaceutical compositions and methods for anesthesiological applications
[patent_app_type] => utility
[patent_app_number] => 16/021973
[patent_app_country] => US
[patent_app_date] => 2018-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6509
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16021973
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/021973 | Pharmaceutical compositions and methods for anesthesiological applications | Jun 27, 2018 | Issued |
Array
(
[id] => 15604157
[patent_doc_number] => 10583118
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-10
[patent_title] => Use of N-acetyl-5-methoxytryptamine or analogues thereof, for promoting the mechanism of implantation of the embryo and related compositions and culture media
[patent_app_type] => utility
[patent_app_number] => 16/020304
[patent_app_country] => US
[patent_app_date] => 2018-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 6743
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16020304
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/020304 | Use of N-acetyl-5-methoxytryptamine or analogues thereof, for promoting the mechanism of implantation of the embryo and related compositions and culture media | Jun 26, 2018 | Issued |
Array
(
[id] => 13504617
[patent_doc_number] => 20180303851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => USE OF SUSTAINED RELEASE DEXAMETHASONE IN POST-CATARACT SURGERY INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 16/018931
[patent_app_country] => US
[patent_app_date] => 2018-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16018931
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/018931 | Use of sustained release dexamethasone in post-cataract surgery inflammation | Jun 25, 2018 | Issued |